10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 255 filers reported holding 10X GENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $611,366 | +74.2% | 14,821 | +135.8% | 1.02% | +164.5% |
| Q2 2023 | $350,954 | -5.5% | 6,285 | -5.6% | 0.39% | -15.4% |
| Q1 2023 | $371,282 | +267.0% | 6,655 | +139.7% | 0.46% | +360.6% |
| Q4 2022 | $101,157 | +23.4% | 2,776 | +26.4% | 0.10% | +20.7% |
| Q3 2022 | $82,000 | -92.7% | 2,196 | -71.5% | 0.08% | -81.6% |
| Q3 2021 | $1,123,000 | -25.7% | 7,717 | 0.0% | 0.44% | -8.8% |
| Q2 2021 | $1,511,000 | – | 7,717 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |